Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHUK | O15111 | 16/20 | 0.59 |
| ▸ | ICOSLG | O75144 | 9/20 | 0.53 |
| ▸ | ICOS | Q9Y6W8 | 9/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | IKBKB | O14920 | 1/20 | 0.50 |
| ▸ | PIM1 | P11309 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.50 |
| ▸ | IKBKG | Q9Y6K9 | 1/20 | 0.50 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1794961 | 0.81 | CHUK (0.62) | CHUKICOSLGICOSMEN1IKBKB | |
| SCHEMBL1797661 | 0.80 | CHUK (0.62) | CHUKICOSLGICOSMEN1IKBKB | |
| SCHEMBL12619326 | 0.80 | CHUK (0.62) | CHUKICOSLGICOSMEN1IKBKB | |
| SCHEMBL13376960 | 0.78 | CHUK (0.69) | CHUKICOSLGICOSMEN1IKBKB | |
| SCHEMBL14253042 | 0.76 | CHUK (1.00) | CHUKICOSLGICOSMEN1IKBKB | |
| SCHEMBL13377026 | 0.75 | CHUK (0.77) | CHUKICOSLGICOSMEN1IKBKB | |
| SCHEMBL5764362 | 0.74 | CHUK (0.54) | CHUKICOSLGICOSMEN1IKBKB | |
| SCHEMBL5764367 | 0.74 | CHUK (0.54) | CHUKICOSLGICOSMEN1IKBKB | |
| SCHEMBL1803665 | 0.74 | ICOSLG (0.54) | CHUKICOSLGICOSMEN1IKBKB | |
| SCHEMBL1803664 | 0.74 | ICOSLG (0.54) | CHUKICOSLGICOSMEN1IKBKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7951801-B2 | For therapy of inflammatory disease and cancer | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2011-05-31 | — | — | US | disclosed |